Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinal Vein Occlusion Among Patients With Type 2 Diabetes: A Propensity Score-Matched Cohort Study.
Min-Kyung LeeBongsung KimKyungdo HanJae-Hyuk LeeMinhee KimMee Kyoung KimKi-Hyun BaekKi-Ho SongHyuk-Sang KwonYoung-Jung RohPublished in: Diabetes care (2021)
In a matched cohort study, we found that SGLT2 inhibitors were associated with a significantly increased risk of RVO. Older patients and those with chronic kidney disease were at higher risk for RVO.